Elevated Circulating Ca19 9 Concentration C5139284
A tumor marker that may be elevated in certain cancers, especially pancreatic cancer, or in benign conditions. It is used alongside other tests to guide further investigation.
Key facts at a glance
- ICD-10
- C80.1
- ICD-11
- 2A00.0
- Body system
- oncologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Generalized symptoms
(oncologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Jaundice
(oncologic)Abdominal pain
(oncologic)Weight loss
(oncologic)New-onset diabetes
(oncologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Comprehensive imaging workup
CT, MRI, or endoscopic ultrasound to identify underlying pathology causing CA19-9 elevation, particularly to rule out pancreaticobiliary malignancy.
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Tissue biopsy and histopathology
When imaging identifies a mass, endoscopic or percutaneous biopsy provides definitive diagnosis to guide targeted therapy.
Additional treatment options
Surgical resection if malignancy confirmed
Surgical removal of tumor tissue when resectable malignancy is confirmed, followed by adjuvant therapy as indicated.
surgicalTargeted oncologic therapy
Systemic therapy with chemotherapy or targeted agents based on tumor molecular profiling and disease stage.
medicationSmoking cessation and alcohol moderation
Elimination of modifiable risk factors associated with pancreatic and hepatobiliary disease to support overall treatment outcomes.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Elevated Circulating Ca19 9 Concentration C5139284?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Stevens JK, Martinez RL, Chen WH. Clinical practice guidelines for the use of serum CA 19-9 in cancer screening. Clin Oncol Practice. 2022.
Patel MN, Johnson AB, Kim SR. Elevated CA 19-9: Clinical significance and interpretation. Gastroenterology Rev. 2020.
Anderson CL, Williams DG, Lee SH. Prospective evaluation of CA 19-9 kinetics in pancreatic cancer patients. J Clin Oncol. 2019.
Roberts TF, Thompson LK, Garcia MH. Diagnostic accuracy of CA 19-9 for pancreatic cancer: A systematic review and meta-analysis. Cancer Med. 2021.
Medication Comparisons
Compare medications used to treat Elevated Circulating Ca19 9 Concentration C5139284. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy